newsfilter
← Latest News
PR Newswire·

Braxia Scientific Reports Encouraging Results of Ketamine Study Showing Significant Reduction in Depressive Symptoms and Suicidality with Ketamine as a Solo Treatment

TORONTO, Sept. 30, 2021 /PRNewswire/ - Braxia Scientific Corp. ("Braxia", or the "Company"), (CSE:BRAX) (OTC:BRAXF) (FWB: 496), a medical research company with clinics providing innovative ketamine treatments for persons with depression and related diso